Our results indicate that the serum levels of interleukin 6 (IL-6), TNFα, and monocyte chemotactic protein 1 (MCP1) were increased in NASH mice, while LPJZ-658 supplementation significantly reversed all of these phenomena (Figure 3E). Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.